These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 37242545)

  • 1. Honey-Related Treatment Strategies in Dry Eye Disease.
    Prinz J; Maffulli N; Fuest M; Walter P; Hildebrand F; Migliorini F
    Pharmaceuticals (Basel); 2023 May; 16(5):. PubMed ID: 37242545
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Placebo administration for dry eye disease: a level I evidence based systematic review and meta-analysis.
    Prinz J; Maffulli N; Fuest M; Walter P; Hildebrand F; Migliorini F
    Int J Clin Pharm; 2022 Oct; 44(5):1087-1101. PubMed ID: 35939178
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chloroquine and Hydroxychloroquine in the Treatment of Dry Eye Disease.
    Prinz J; Maffulli N; Fuest M; Walter P; Hildebrand F; Migliorini F
    Diseases; 2023 Jun; 11(2):. PubMed ID: 37366873
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy of Topical Administration of Corticosteroids for the Management of Dry Eye Disease: Systematic Review and Meta-Analysis.
    Prinz J; Maffulli N; Fuest M; Walter P; Bell A; Migliorini F
    Life (Basel); 2022 Nov; 12(11):. PubMed ID: 36431067
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acupuncture for the management of dry eye disease.
    Prinz J; Maffulli N; Fuest M; Walter P; Hildebrand F; Migliorini F
    Front Med; 2022 Dec; 16(6):975-983. PubMed ID: 36152126
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Systemic Conditions Associated with Severity of Dry Eye Signs and Symptoms in the Dry Eye Assessment and Management Study.
    Yu K; Bunya V; Maguire M; Asbell P; Ying GS;
    Ophthalmology; 2021 Oct; 128(10):1384-1392. PubMed ID: 33785415
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Matrix Metalloproteinase 9 Testing in Dry Eye Disease Using a Commercially Available Point-of-Care Immunoassay.
    Messmer EM; von Lindenfels V; Garbe A; Kampik A
    Ophthalmology; 2016 Nov; 123(11):2300-2308. PubMed ID: 27665213
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy and safety of manuka honey for dry eye.
    Hu J; Kong L; Zhu S; Ju M; Zhang Q
    Clin Exp Optom; 2023 Jul; 106(5):455-465. PubMed ID: 35950413
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The IMPACT study: a prospective evaluation of the effects of cyclosporine ophthalmic emulsion 0.05% on ocular surface staining and visual performance in patients with dry eye.
    Stonecipher KG; Torkildsen GL; Ousler GW; Morris S; Villanueva L; Hollander DA
    Clin Ophthalmol; 2016; 10():887-95. PubMed ID: 27257373
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Corneal permeability changes in dry eye disease: an observational study.
    Fujitani K; Gadaria N; Lee KI; Barry B; Asbell P
    BMC Ophthalmol; 2016 May; 16(1):53. PubMed ID: 27177442
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevalence of Dry Eye Disease Among Individuals Scheduled for Cataract Surgery in a Norwegian Cataract Clinic.
    Graae Jensen P; Gundersen M; Nilsen C; Gundersen KG; Potvin R; Gazerani P; Chen X; Utheim TP; Utheim ØA
    Clin Ophthalmol; 2023; 17():1233-1243. PubMed ID: 37138823
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of OTX-101 in Patients with Dry Eye Disease at Day 14 of Treatment: Ocular Surface Endpoint Results from the Phase 2b/3 Clinical Trial.
    Schechter BA; Urbieta M; Bacharach J; Toyos M; Smyth-Medina R; Mitchell B; Luchs JI
    Clin Ophthalmol; 2022; 16():4145-4151. PubMed ID: 36536927
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Alteration of corneal biomechanical properties in patients with dry eye disease.
    Satitpitakul V; Taweekitikul P; Puangsricharern V; Kasetsuwan N; Reinprayoon U; Kittipibul T
    PLoS One; 2021; 16(7):e0254442. PubMed ID: 34252118
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy of hypotonic 0.18% sodium hyaluronate eye drops in patients with dry eye disease.
    Lee HS; Ji YS; Yoon KC
    Cornea; 2014 Sep; 33(9):946-51. PubMed ID: 24915018
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association Between Depression and Severity of Dry Eye Symptoms, Signs, and Inflammatory Markers in the DREAM Study.
    Zhou Y; Murrough J; Yu Y; Roy N; Sayegh R; Asbell P; Maguire MG; Ying GS;
    JAMA Ophthalmol; 2022 Apr; 140(4):392-399. PubMed ID: 35266971
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association between systemic activity ındex and dry eye severity in patients with primary Sjögren syndrome.
    Ozek D; Kemer OE; Omma A
    Arq Bras Oftalmol; 2019; 82(1):45-50. PubMed ID: 30403265
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Predictors of Discordance between Symptoms and Signs in Dry Eye Disease.
    Vehof J; Sillevis Smitt-Kamminga N; Nibourg SA; Hammond CJ
    Ophthalmology; 2017 Mar; 124(3):280-286. PubMed ID: 28024826
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Randomised controlled trial of topical antibacterial Manuka (Leptospermum species) honey for evaporative dry eye due to meibomian gland dysfunction.
    Albietz JM; Schmid KL
    Clin Exp Optom; 2017 Nov; 100(6):603-615. PubMed ID: 28585260
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Randomized masked trial of the clinical efficacy of MGO Manuka Honey microemulsion eye cream for the treatment of blepharitis.
    Craig JP; Cruzat A; Cheung IMY; Watters GA; Wang MTM
    Ocul Surf; 2020 Jan; 18(1):170-177. PubMed ID: 31759183
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Randomised assessor
    Li AL; Li SL; Kam KW; Young AL
    Br J Ophthalmol; 2022 Jun; 106(6):777-780. PubMed ID: 33419788
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.